Relationship between doxorubicin binding ability and tumor volume decrease after chemotherapy in adult malignant soft tissue tumors in the extremities

Anticancer Research

Volumn 20, Issue 5 C, 2000, Pages 3813-3816

  Kusuzaki, K ^a   Shinjo, H ^a   Murata, H ^a   Takeshita, H ^a   Hashiguchi, S ^a   Nozaki, T ^a   Emoto, K ^a   Ashihara, T ^a   Hirasawa, Y ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Chemosensitivity; Doxorubicin binding; Malignant soft tissue tumor; Tumor volume

Indexed keywords

CARBOPLATIN; DOXORUBICIN; IFOSFAMIDE; PIRARUBICIN;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CHEMOSENSITIVITY; CLINICAL ARTICLE; DRUG BINDING; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; LIMB TUMOR; LUNG METASTASIS; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MYOSARCOMA; OSTEOSARCOMA; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; SOFT TISSUE CANCER; SYNOVIAL SARCOMA; TUMOR NECROSIS; TUMOR REGRESSION; TUMOR VOLUME;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARM; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; DOXORUBICIN; FEMALE; HUMANS; LIPOSARCOMA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEOSARCOMA; SARCOMA, SYNOVIAL; SOFT TISSUE NEOPLASMS; THIGH;

EID: 0034528634     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. In vitro assay of nuclear uptake of doxorubicin hydrochloride in osteosarcoma cells of dogs
2. Adriamycin binding assay: A valuable chemosensitivity test in human osteosarcoma
3. An assay to measure adriamycin binding in osteosarcoma cells
4. Experimental models for study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines
5. Relation between cellular DOX binding ability to nuclear DNA and histologic response to preoperative chemotherapy in patients with osteosarcoma
6. Relationship between P-glycoprotein positivity, doxorubicin binding ability and histologic response to chemotherapy in osteosarcomas
7. Toxicity and response criteria of eastern cooperative oncology group
8. Southwest oncology group standard response criteria, endpoint definitions and toxicity criteria
9. Criteria for the evaluation of direct effects of solid cancer chemotherapy
10. Morphological changes in osteosarcoma after chemotherapy - COSS 80
11. Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma
12. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: An analysis of 2,185 patients treated with anthracycline-containing first-line regimens- a european organization for research and treatment of cancer soft tissue and bone sarcoma group study
13. Long-term outcome of patients with American Joint Committee on cancer stage IIB extremity soft tissue sarcomas
14. Multidrug resistance phenotype in high grade soft tissue sarcoma. Correlation of P-glycoprotein immunohistochemistry with pathologic response to chemotherapy
15. Primary chemotherapy and delayed surgery (Neoadjuvant chemotherapy) for osteosarcoma of extremities. The Istituto Rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin
16. Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience
17. Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy